The synthesis of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, represents a complex complicated synthetic process. Initial routes focused on peptide portion coupling, utilizing solid-phase synthesis methodologies to build the long peptide sequence. Subsequent research has explored alternative approaches, including e… Read More